Filtered By:
Infectious Disease: COVID-19
Vaccination: Vaccines

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 391 results found since Jan 2013.

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data
In conclusion, both virus-based COVID-19 vaccines show more SAEs than BNT, but the frequency of the SAE type in the different age groups differs, suggesting that the mechanisms responsible of SAEs overlap only partly.PMID:34710832 | PMC:PMC8547775 | DOI:10.1016/j.jaut.2021.102742
Source: Journal of Autoimmunity - October 28, 2021 Category: Allergy & Immunology Authors: Luigi Cari Mahdieh Naghavi Alhosseini Paolo Fiore Sabata Pierno Sabrina Pacor Alberta Bergamo Gianni Sava Giuseppe Nocentini Source Type: research

COVID-19 pandemic: Real-world experiences and lessons learned
Interv Neuroradiol. 2021 Oct;27(1_suppl):36-38. doi: 10.1177/15910199211035904.ABSTRACTThe COVID-19 pandemic has disrupted all walks of life on an unprecedented scale. In the following report, we recount the experience of stroke and neurointerventional practitioners from different parts of India. It was written in September 2020 when the first wave of the pandemic was at its zenith in India and vaccines were not yet available.PMID:34747646 | DOI:10.1177/15910199211035904
Source: Interventional Neuroradiology - November 8, 2021 Category: Radiology Authors: P R Srijithesh Shakir H Hakim Source Type: research

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine
This population based study evaluated the short-term risk of severe cardiovascular risks among French residents 75 years or older after they received the BNT162b2 mRNA vaccination.
Source: JAMA - Journal of the American Medical Association - November 22, 2021 Category: General Medicine Source Type: research

Fulminant reversible cerebral vasoconstriction syndrome in breakthrough COVID 19 infection
We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay.
Source: Journal of Stroke and Cerebrovascular Diseases - November 25, 2021 Category: Neurology Authors: Somdattaa Ray, Vikram V Kamath, Arjun Raju P, Rajesh K.N, Shalini N Source Type: research

Covid: Two boys from same school die within a week of each other after contracting virus
A TEENAGE boy died of stroke after catching Covid within a week of the death of a fellow pupil at the same school, who also had COVID-19. Both pupils, who passed away in October half-term, were due to have vaccination just weeks before their deaths.
Source: Daily Express - Health - December 11, 2021 Category: Consumer Health News Source Type: news

After she lost her hair from COVID-19, 7-year-old Regina girl excited for 1st vaccine dose
Cedar Herle was eager to get the pediatric COVID-19 vaccine after experiencing first-hand the long-term effects of the disease. She lost all of her hair after contracting COVID-19 a year ago, while her mother suffered a COVID-related stroke.
Source: CBC | Health - December 14, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

After she lost her hair from COVID-19, 7-year-old Regina girl excited about 1st vaccine dose
Cedar Herle was eager to get the pediatric COVID-19 vaccine after experiencing first-hand the long-term effects of the disease. She lost all of her hair after contracting COVID-19 a year ago, while her mother suffered a COVID-related stroke.
Source: CBC | Health - December 14, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

What should we do about vaccination of patients on anti-CD20 antibody therapy?
The SARS-CoV-2 antibody response was decreased in patients with multiple sclerosis (MS) who were infected with COVID-19 and received anti-CD20 therapy Vaccination efforts for COVID-19 are currently underway worldwide. At present, there is insufficient evidence of the vaccine’s efficacy and safety in patients with neurological diseases, such as stroke, dementia and intractable neurological diseases. Despite the fact that many patients with neurological diseases are elderly and often have systemic complications, I believe that neurologists should nonetheless actively recommend vaccination to their patients. However, th...
Source: Journal of Neurology, Neurosurgery and Psychiatry - December 14, 2021 Category: Neurosurgery Authors: Shimohata, T. Tags: COVID-19 Editorial commentaries Source Type: research

Neurological disorders seen during second wave of SARS-CoV-2 pandemic from two tertiary care centers in central and Southern Kerala
Conclusion: During the SARS-CoV-2 pandemic, CAND and PVND have been emerging. Association of some of these may be fortuitous; however it is worth mentioning as pathogenic mechanisms of COVID-19 affecting various organ systems still remain unclear. Moreover, this may be helpful in future studies designing management options.
Source: Annals of Indian Academy of Neurology - December 17, 2021 Category: Neurology Authors: Minu George Neena Baby Ameen Azad Aswathy Rajan Suresh Kumar Radhakrishnan Source Type: research

Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia
CONCLUSIONS: Vaccine-induced immune thrombotic thrombocytopenia is a serious complication of vaccination that is not feasible to anticipate or prevent. When the patient presents with sustained headache, neurologic symptoms/signs, abdominal pain, dyspnea, or limb pain/swelling beginning 5–30 days post vaccination, platelet count and d-dimer must be measured, and imaging for thrombosis performed. Confirmation of vaccine-induced immune thrombotic thrombocytopenia diagnosis should be ordered (platelet factor 4/polyanion enzyme-linked immunosorbent assay; platelet factor 4–enhanced platelet activation testing) as treatm...
Source: Critical Care Medicine - December 20, 2021 Category: Emergency Medicine Tags: Online Review Article Source Type: research